Palifermin and fluid retention Patient Reports February 12, 2012
Palifermin Side Effects Report #5067135-4
Palifermin side effect was reported by a Physician from BELGIUM on July 19, 2006. Female patient, weighting 165.3 lb, was diagnosed with peripheral blood stem cell apheresis and was treated with Palifermin. After drug was administered, patient experienced the following side effects: burning sensation, capillary leak syndrome, fluid retention, hypersensitivity, rash
, stomatitis. Palifermin dosage: unknown. During the same period patient was treated with CARMUSTINE, ETOPOSIDE, CYTARABINE, METHOTREXATE. Patient recovered.Palifermin Side Effects Report #5122698-5
Palifermin side effect was reported by a Physician from BELGIUM on July 19, 2006. Female patient, weighting 165.3 lb, was diagnosed with peripheral blood stem cell apheresis and was treated with Palifermin. After drug was administered, patient experienced the following side effects: bacteraemia, burning sensation, capillary leak syndrome, febrile neutropenia, fluid retention, hypersensitivity, mucosal inflammation, rash
, stomatitis. Palifermin dosage: unknown. During the same period patient was treated with CARMUSTINE, ETOPOSIDE, CYTARABINE, METHOTREXATE, MELPHALAN, CISPLATIN, NEUPOGEN. Patient was hospitalized. Patient recovered.Palifermin Side Effects Report #5170386-1
Palifermin side effect was reported by a Physician from BELGIUM on July 19, 2006. Female patient, weighting 165.3 lb, was diagnosed with peripheral blood stem cell apheresis and was treated with Palifermin. After drug was administered, patient experienced the following side effects: bacteraemia, burning sensation, capillary leak syndrome, febrile neutropenia, fluid retention, hypersensitivity, mucosal inflammation, rash
, stomatitis. Palifermin dosage: unknown. During the same period patient was treated with CARMUSTINE, ETOPOSIDE, CYTARABINE, METHOTREXATE, MELPHALAN, CISPLATIN, NEUPOGEN. Patient was hospitalized. Patient recovered.Palifermin Side Effects Report #5078201-1
Palifermin side effect was reported by a Physician from BELGIUM on June 01, 2006. Male patient, weighting 123.5 lb, was diagnosed with mucosal inflammation and was treated with Palifermin. After drug was administered, patient experienced the following side effects: cytomegalovirus infection
, dermatitis exfoliative, fluid retention, oedema, pruritus, pyrexia, rash
. Palifermin dosage: unknown. During the same period patient was treated with ARACYTIN, ETOPOSIDE, CARMUSTINE, CYCLOPHOSPHAMIDE, OFLOXACIN, FLUCONAZOLE, POTASSIUM CHLORIDE, MAGNESIUM. Patient was hospitalized. Patient recovered.Palifermin Side Effects Report #5078204-7
Palifermin side effect was reported by a Physician from BELGIUM on June 01, 2006. Female patient, weighting 110.2 lb, was diagnosed with mucosal inflammation and was treated with Palifermin. After drug was administered, patient experienced the following side effects: dermatitis exfoliative, face oedema, fluid retention, oedema mucosal, pain
, pruritus, sodium retention, tongue oedema, vomiting. Palifermin dosage: unknown. During the same period patient was treated with MELPHALAN, TROPISETRON, ZOFRAN, LITICAN, TRANXENE, NEUPOGEN, POTASSIUM CHLORIDE, POLARAMINE. Patient recovered.Palifermin Side Effects Report #5024291-1
Palifermin side effect was reported by a Physician from BELGIUM on June 01, 2006. Female patient, weighting 110.2 lb, was diagnosed with mucosal inflammation and was treated with Palifermin. After drug was administered, patient experienced the following side effects: dermatitis exfoliative, face oedema, fluid retention, nausea
, oedema mucosal, pain
, pruritus, sodium retention, tongue oedema. Palifermin dosage: unknown. Patient recovered.Palifermin Side Effects Report #5024304-7
Palifermin side effect was reported by a Physician from BELGIUM on June 01, 2006. Male patient, weighting 123.5 lb, was diagnosed with mucosal inflammation and was treated with Palifermin. After drug was administered, patient experienced the following side effects: dermatitis exfoliative, fluid retention, oedema, pruritus, pyrexia. Palifermin dosage: unknown. During the same period patient was treated with ARACYTIN, ETOPOSIDE, OFLOXACIN, FLUCONAZOLE, POTASSIUM CHLORIDE, MAGNESIUM, POLARAMINE, FRUSEMIDE. Patient was hospitalized. Patient recovered.
Palifermin and fluid retention 